Drug – bio-affecting and body treating compositions – Nonspecific immunoeffector – per se ; or nonspecific... – Synthetic or structurally-modified peptidoglycan or...
Patent
1980-08-06
1981-09-15
Rosen, Sam
Drug, bio-affecting and body treating compositions
Nonspecific immunoeffector, per se ; or nonspecific...
Synthetic or structurally-modified peptidoglycan or...
424305, 424308, 424317, 424324, A61K 31335, A61K 31215, A61K 3119, A61K 31165
Patent
active
042897858
ABSTRACT:
5-Oxa-17-phenyl-18,19,20-trinor-PGF.sub.1 .alpha. alkyl esters and 5-oxa-17-phenyl-18,19,20-trinor PGF.sub.1 .alpha. amide are combined with certain other prostaglandins in synergistic combinations to induce menses in female primates, preferably humans. These synergistic prostaglandin compositions have improved efficacy and safety.
REFERENCES:
patent: 3864387 (1975-02-01), Nelson
patent: 3978229 (1976-08-01), Matsumoto
patent: 4045449 (1977-08-01), Bundy
Rosen Sam
The Upjohn Company
Welch Lawrence T.
LandOfFree
Method and compositions involving prostaglandins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and compositions involving prostaglandins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and compositions involving prostaglandins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-391124